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Background: Preeclampsia is still the main cause of morbidity and mortality not only for mothers 
but also for fetal. The concept of early and late-onset preeclampsia is a more modern concept, and 
it is stated that these two entities have different etiologies and must be considered as different 
forms of the disease. This study aims to analyzing differences in maternal characteristics (age, 
number of parity, history of hypertension and diabetes mellitus) and laboratory results (platelet, 
ewitz, Lactic Acid Dehydrogenase/LDH) and to analyzing differences in maternal complications 
(maternal death, eclampsia, impending eclampsia, pulmonary edema, (hemolysis, elevated liver 
enzyme levels, and low platelet levels/HELLP syndrome) and perinatal complications (perinatal 
death, Intrauterine Growth Restriction/IUGR, fetal hypoxia and fetal distress) between early and 
late-onset preeclampsia. This study aimed to investigate the maternal characteristics and the 
effects of early and late-onset types of preeclampsia on maternal and perinatal complications. 
Subjects and Method: This was a retrospective cohort study. The study was carried out at Dr. 
Moewardi Hospital, Surakarta, from January 1, 2016, to December 31, 2017. A total of 548 
pregnant mothers with preeclampsia was selected for this study. The dependent variable was the 
incidence of preeclampsia. The independent variables were age, parity, hypertension, diabetes 
Mellitus, platelets, LDH, and proteinuria. The data were obtained from the medical record and 
analyzed by a multiple linear regression. 
Results: The number of patients with early-onset (162) was less than late-onset (386). More 
patients have multiparity in early and late-onset. In early-onset preeclampsia, thrombocytopenia 
and LDH increase tend to be present, and ewitz >+1. Early-onset preeclampsia tends to result in 
more maternal and perinatal complications. 
Conclusion: The incidence of early-onset is less than late-onset, but early-onset provides worse 
complications for both maternal and perinatal. 
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BACKGROUND 
Preeclampsia is still the main cause of 
morbidity and mortality not only for 
mothers but also for fetal (Ananth and 
Wapner, 2013). In the world, the preva-
lence of preeclampsia is around 5% -15% of 
all pregnancies (Srinivas et al., 2009).In 
Indonesia, 30%-40% ofcases of preeclamp-
sia are the cause of death in pregnant 
women and 30%-50% are the cause of peri-
natal death. Specifically for hypertension in 
pregnancy, including preeclampsia, is 
found in persistent numbers and tends to 
increase in 5%-7% of pregnancies and is the 
most frequent medical complication in 
pregnancy. About 70% of women diagnosed 
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with hypertension in pregnancy are pre-
eclampsia. At the Dr. Moewardi Hospital, 
Surakarta, the mortality rate of pregnant 
women in 2012 caused by preeclampsia was 
63.30% in which 19 women died from the 
total of 30 pregnant women and in 2013 
was 57.14% in which 12 women died from 
the total of 21 pregnant women (Sulistyo-
wati et al., 2016). 
Preeclampsia is diagnosed when a 
normotensive pregnant woman at first, 
after 20 weeks of pregnancy her blood 
pressure is higher than 140/90mmHg, with 
or without proteinuria, followed by throm-
bocytopenia, pulmonary edema and organ 
lesions that affect the end organs such as 
kidneys, brain or liver (ACOG, 2013).The 
mother and fetus are at high risk of getting 
complications that will be very detrimental 
if the right action is not implemented 
earlier. 
The exact etiology of preeclampsia is 
still unclear, suspected endothelial dysfunc-
tion plays an important role in the develop-
ment of preeclampsia (Mateus et al., 2011). 
Until now there is no effective treatment 
that has been found to prevent preeclamp-
sia, other than giving birth to a fetus and 
placenta (Woods et al., 2011). 
The complications arising from pre-
eclampsia are including eclampsia, hemo-
lytic-elevated liver enzymes and low plate-
lets (HELLP syndrome), Disseminated In-
travascular Coagulopathy (DIC), emergency 
hypertension, encephalopathy hypertension 
and blindness of the cerebral cortical region 
(Cunningham et al., 2013). 
Preeclampsia is divided into gestatio-
nal age <34 weeks (early-onset) and gesta-
tional age ≥ 34 weeks of (late-onset). The 
concept of early and late-onset preeclamp-
sia is a more modern concept, and it is 
stated that these two entities have different 
etiologies and must be considered as differ-
rent forms of the disease. Early-onset pre-
eclampsia is caused by placentation dis-
orders in which there is a disturbance of 
spiral arterial remodeling in myometrial 
and also trophoblast invasion in the spiral 
arteriolar wall. In late-onset preeclampsia, 
a hypothesis is found regarding the mater-
nal constitution which causes maternal 
endothelial damage which has nothing to 
do with damage due to trophoblastic 
invasion.  
 
SUBJECTS AND METHOD 
1. Study Design 
This was a retrospective cohort study con-
ducted at the Dr. Meowardi Hospital, Sura-
karta, Central Java from January 1, 2016, to 
December 31, 2017. 
2. Population and Sampling 
The population in this study was all preg-
nant mothers with preeclampsia. The pati-
ent’s data were collected from medical 
records of Dr. Moewardi Hospital, Sura-
karta by holding on to the code of severe 
preeclampsia, namely O14.1 within a period 
of two years, January 1, 2016, until Decem-
ber 31, 2017. A total of 548 pregnant 
mothers was selected for this study. With 
inclusion criteria are all data on preeclamp-
sia patients who gave birth at the Dr. 
Moewardi Hospital, Surakarta with the ICD 
10 code number is O14.1 and exclusion cri-
teria are all patient data from Dr. Moewardi 
Hospital, Surakarta which is not with ICD 
10 code number 014.1 and incomplete data.  
3. Study Variable 
The dependent variable was the incidence 
of preeclampsia. The independent variables 
were age, parity, hypertension, diabetes 
mellitus, platelets, LDH, and ewitz (protein-
uria). 
4. Data Analysis 
The analysis used univariate, bivariate (Chi-
square), and multiple linear regression with 
95% confidence intervals and p < 0.05, and 
processed using SPSS (Software Package 
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for Social Science) software. The study was 
approved by the ethics committee Dr. 
Moewardi Hospital on April 24, 2018, with 
the number of 521 / IV / HREC / 2018. 
 
RESULTS 
From the data obtained it was found that 
there were 1845 deliveries over a period of 
two years, patients with the preeclampsia 
code O14.1 obtained 548 patient data. From 
these data, the number of patients with 
early-onset preeclampsia was 162 patients 
(29.60%) and 386 patients (70.40%) with 
late-onset preeclampsia. 
Table 1. Sample Characteristics 
Variables 
Preeclampsia 





N % N % 
Age        
<20 years old 4 2.5 13 3.4   0.714 
 20-34 years old 99 61.1 236 61.1    
>34 years 59 36.4 137 35.5    
Parity        
1  38 23.5 125 32.4 1.13 1.01 to 1.26 0.037 
>1  124 76.5 261 6.6    
History of Hypertension        
No 105 64.8 257 66.6 1.05 0.81 to 1.35 0.691 
Yes 57 35.2 129 33.4    
History of DM        
No 146 90.1 364 93.1 1.73 0.93 to 3.21 0.079 














1.89 to 4.30 
 
< 0.001 
Yes( <100,000) 42 25.9 35 9.1    
LDH        
No (< 600U/l) 90 55.6 346 89.6 4.28 3.05 to 6.02 <0.001 
Yes (>600 U/l) 72 44.4 40 10.4    
Ewitz        
+1 47 29.0 233 60.4 1.79 1.53 to 2.09 <0.001 
>+1 115 71.0 153 39.6    
 
Table 1 showed there was no significant 
difference in maternal age characteristics 
between early-onset preeclampsia and late-
onset preeclampsia (p= 0.850). There was a 
significant difference between parity of 
early and late-onset preeclampsia mothers 
(OR= 1.13; p= 0.037), where early-onset 
preeclampsia was 76.5% with parity >1, 
while late-onset preeclampsia was 67.6% 
with parity >1 time. There was no signify-
cant difference in the incidence of hyper-
tension between early-onset preeclampsia 
and late-onset preeclampsia (p= 0.690). 
There was no significant difference in the 
incidence of diabetes mellitus between 
early-onset preeclampsia and late-onset 
preeclampsia (p=0.079). There was a signi-
ficant difference in the incidence of throm-
bocytopenia between early and late-onset 
preeclampsia (OR= 2.85; p<0.001), where 
early-onset preeclampsia was 25.9% with 
platelets <100,000, while late-onset pre-
eclampsia 9.1% with platelets <100.000. 
There was a significant difference in the 
incidence of LDH> 600 between early-
onset preeclampsia and late-onset pre-
eclampsia (OR= 4.28; p <0.001), where 
early-onset preeclampsia patients were 
44.4% with LDH> 600, whereas late-onset 
preeclampsia patients were 10.4% with 
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LDH> 600. There was a significant differ-
rence in the incidence of quality proteinuria 
> +1 between early-onset preeclampsia and 
late-onset preeclampsia (OR= 1.79; p 
<0.001), where early-onset preeclampsia 
patients were 71.0% with proteinuria > +1, 
whereas preeclampsia patients late-onset 
39.6% with proteinuria > +1. In this study 
the distribution for proteinuria > +1, which 
means +2, +3 and +4, the distribution 
obtained is +2 by 53%, +3 by 39%, and +4 
by 8%.  





(n=386) OR 95% CI p 
N % N % 
Maternal death        
No 151 93.2 384 99.5 13.10 2.93 to 58.46 <0.001 
Yes 11 6.8 2 0.5    
Eclampsia        
No 145 89.5 371 96.1 2.70 1.38 to 5.27 0.003 
Yes 17 10.5 15 3.9    
Impending Eclampsia        
No 134 82.7 330 85.5 1.19 0.78 to 1.80 0.436 
Yes 28 17.3 56 14.5    
Pulmonary edema        
No 128 79.0 363 94.0 3.52 2.14 to 5.78 <0.001 
Yes 34 21.0 23 6.0    
HELLP syndrome        
No 81 50.0 351 90.9 5.51 3.88 to 7.83 <0.001 
Yes 81 50.0 35 9.1    
 
Table 2 showed that there was a 
significant difference in the incidence of 
maternal mortality between early-onset 
preeclampsia and late-onset preeclampsia 
(OR= 13.10; p<0.001), where early-onset 
preeclampsia patients were 6.8% and late-
onset 0.5%. There was a significant differ-
rence in eclampsia between early and late-
onset preeclampsia (OR= 2.70; p=0.003), 
where early-onset preeclampsia patients 
were 10.50% while late-onset 3.90%. There 
was no significant difference in the inci-
dence of impending eclampsia between 
early and late-onset preeclampsia (p= 
0.410). There was a significant difference in 
the incidence of pulmonary edema between 
early and late-onset preeclampsia (OR= 
3.52; p<0.001), where early-onset pre-
eclampsia patients were 21% and 6% late-
onset patients with pulmonary edema. 
There was a significant difference in 
HELLP syndrome incidence between early 
and late-onset preeclampsia (OR= 5.51; 
p<0.001), where early-onset preeclampsia 
patients were 50% while late-onset 9.1% 
with HELLP syndrome.  
Table 3 showed that there was a 
significant difference in the incidence of 
perinatal mortality between early and late-
onset preeclampsia (OR= 8.45; p<0.001) in 
which early-onset preeclampsia patients 
were 43.8% while 5.2% of late-onset pre-
eclampsia with perinatal mortality. There 
was a significant difference in the incidence 
of IUGR between early and late-onset pre-
eclampsia (OR= 6.18; p<0.001), where 
early-onset preeclampsia patients were 
51.2%, while late-onset was 8.3% with 
IUGR. There was a significant difference in 
the incidence of fetal distress/hypoxia 
between early and late-onset preeclampsia 
(OR= 2.88; p<0.001), where early-onset 
preeclampsia patients were 56.8% while 
late-onset 19.7% with fetal distress/ 
hypoxia.
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(n=386) OR 95% CI p 
N % N % 
Perinatal death        
No 91 56.2 366 94.8 8.45 5.33 to 13.41 <0.001 
Yes 71 43.8 20 5.2   
IUGR        
No 79 48.8 354 91.7 6.18 4.29 to 8.89 <0.001 
Yes 83 51.2 32 8.3    
Fetal Hypoxia/Fetal 
Distress 
    
   
No 70 43.2 310 80.3 2.88 2.26 to 3.67 <0.001 
Yes 92 56.8 76 19.7    
 





Lower limit Upper limit 
Age 
    20-34 years 0.91 0.270 3.090 0.815 
>34 years 0.85 0.240 3.076 0.791 
Parity (>1) 1.40 0.853 2.308 0.183 
Hypertension (Yes) 0.84 0.541 1.332 0.476 
Diabetes Mellitus (Yes) 1.62 0.752 3.530 0.216 
Platelets (<100.000) 1.81 1.033 3.175 0.038 
LDH (>600) 4.37 2.668 7.185 <0.001 
Proteinuria (>+1) 2.14 1.369 3.345 <0.001 
 
Table 4 showed that greatly influence the 
incidence of late-onset preeclampsia are 
LDH variables, with<0.001 and OR= 4.37 
(2.66 to 7.18), where patients with LDH > 
600 are at risk for early-onset preeclampsia 
4.37 (2.66 to 7.18). Other variables that 
affected were proteinuria (p= 0.001 and 
OR= 2.14 (1.36 to 3.34) and platelets p= 
0.038 and OR= 1.81 (1.03 to 3.17). 
 
DISCUSSION 
1. The effect of maternal age towards 
preeclampsia 
There was no significant difference in ma-
ternal age characteristics between early-on-
set preeclampsia and late-onset preeclamp-
sia (p= 0.850). In this study both show that 
the age range of 20 to 34 years is the age at 
which preeclampsia is more common both 
early and late-onset. This research is in 
accordance with the theory which states 
that nutrition in pregnant women plays a 
role in the incidence of preeclampsia, where 
women aged > 30 years the level of 
micronutrients in the blood during 
pregnancy is lower when compared to 
young age (Danielle et al., 2014). 
2. The effect of parity towards pre-
eclampsia 
There was a significant difference between 
parity of early and late-onset preeclampsia 
mothers where early-onset preeclampsia 
was 76.5% with parity > 1, while late-onset 
preeclampsia was 67.6% with parity> 1 
time. The results of this study indicate that 
the characteristics of preeclampsia women 
are more directed at parity > 1, which is 
related to maternal stress factors. A large 
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number of children (multiparous) is one of 
the causes of maternal stress. Psychological 
events such as high-stress levels, anxiety or 
depression can directly or indirectly affect 
pregnancy because it causes preeclampsia. 
Psychological stress can affect up to 18% in 
pregnant women, where there is a change 
in the functioning of the neuroendocrine 
system and the immune system. Dangerous 
conditions can directly change the hypo-
thalamic-pituitary-adrenal (HPA) axis, 
which leads to increased cortisol levels and 
related changes in cellular immunity. High 
cortisol levels are associated with hyper-
tension and endothelial dysfunction (Pris-
cila et al., 2011). 
3. The effect of hypertension towards 
preeclampsia 
This study shows no significant difference 
in the incidence of hypertension between 
early-onset preeclampsia and late-onset 
preeclampsia. This is in line with research 
in Washington, which states that hyper-
tension can be at risk for mothers with early 
and late-onset preeclampsia (Lisonkova 
and Joseph, 2013).  
4. The effect of diabetes mellitus to-
wards preeclampsia 
This study shows no significant difference 
in the incidence of diabetes mellitus 
between early-onset preeclampsia and late-
onset preeclampsia. This is in line with 
research in Washington, which states that a 
history of Diabetes mellitus can be at risk in 
mothers with early and late-onset pre-
eclampsia (Lisonkova and Joseph, 2013). 
5. The effect of thrombocytopenia to-
wards preeclampsia 
This study shows a significant difference in 
the incidence of thrombocytopenia between 
early and late-onset preeclampsia where 
early-onset preeclampsia was 25.9% with 
platelets <100.000, while late-onset pre-
eclampsia 9.1% with platelets <100.000. 
6. The effect of LDH towards pre-
eclampsia 
This study shows a significant difference in 
the incidence of LDH> 600 between early-
onset preeclampsia and late-onset pre-
eclampsia where early-onset preeclampsia 
patients were 44.4% with LDH> 600, 
whereas late-onset preeclampsia patients 
were 10.4% with LDH> 600 This is in line 
with research conducted in women in Ame-
rica with results in early-onset of lesions in 
the placenta that cause abnormalities in the 
umbilical arteries and uterine arteries, 
resulting in lysis, thrombocytopenia, IUGR, 
HELLP syndrome. Whereas, for late-onset, 
there is no significant disturbance in the 
placenta, commonly seen in patients with 
obesity and cardiovascular disease (Mifsud 
and Sebire, 2014).  
7. The effect of quality proteinuria to-
wards preeclampsia 
This study shows a significant difference in 
the incidence of quality proteinuria >+1 
between early-onset preeclampsia and late-
onset preeclampsia where early-onset pre-
eclampsia patients were 71.0% with pro-
teinuria >+1, whereas preeclampsia pati-
ents late-onset 39.6% with proteinuria >+1. 
In this study the distribution for protein-
uria > +1, which means +2, +3 and +4, the 
distribution obtained is +2 by 53%, +3 by 
39%, and +4 by 8%. This is related to the 
basic theory of early-onset preeclampsia 
that results from trophoblast invasion 
which causes endothelial damage to blood 
vessels throughout the maternal body 
(Mifsud and Sebire, 2014). 
8. The effect of maternal mortality to-
wards preeclampsia 
This study shows a significant difference in 
the incidence of maternal mortality 
between early-onset preeclampsia and late-
onset preeclampsia where early-onset pre-
eclampsia patients were 6.8% and late-
onset 0.5%. Research in women in the 
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Netherlands concluded that early-onset 
preeclampsia causes more maternal and 
infant morbidity and mortality (Bounde-
wijn, 2008). 
9. The effect of eclampsia towards 
preeclampsia 
This study shows a significant difference in 
eclampsia between early and late-onset 
preeclampsia where early-onset preeclamp-
sia patients were 10.50% while late-onset 
3.90%. This is consistent with research in 
Turkish women, concluding that early-
onset preeclampsia increases the risk of 
maternal mortality by twenty times com-
pared with late-onset preeclampsia (Hale-
nur et al., 2015). 
10. The effect of impending eclamp-
sia towards preeclampsia 
This study shows no significant difference 
in the incidence of impending eclampsia 
between early and late-onset preeclampsia. 
Where early-onset preeclampsia patients 
were 17.30% and late-onset were 14.50% 
with impending eclampsia. 
11. The effect of pulmonary edema 
towards preeclampsia 
This study shows a significant difference in 
the incidence of pulmonary edema between 
early and late-onset preeclampsia where 
early-onset preeclampsia patients were 21% 
and 6% late-onset patients with pulmonary 
edema. It is stated that early-onset pre-
eclampsia is preeclampsia that has occurred 
at < 34 weeks gestation and is more due to 
trophoblast invasion that has occurred at a 
young gestational age, resulting in long 
enough endothelial damage in the maternal 
body which can cause disturbances in the 
body's circulation increased pulmonary 
capillary permeability that causes pulmo-
nary edema (Peter et al., 2003). 
12. The effect of HELLP syndrome to-
wards preeclampsia 
This study shows a significant difference in 
HELLP syndrome incidence between early 
and late-onset preeclampsia where early-
onset preeclampsia patients were 50% 
while late-onset 9.1% with HELLP syn-
drome. This is consistent with studies that 
mention early-onset preeclampsia is asso-
ciated with higher maternal, perinatal mor-
bidity and mortality, especially in cases 
such as eclampsia and HELLP syndrome 
(Hutcheon et al., 2011).  
13. The effect of perinatal mortality to-
wards preeclampsia 
This study shows a significant difference in 
the incidence of perinatal mortality 
between early and late-onset preeclampsia 
in which early-onset preeclampsia patients 
were 43.8% while 5.2% of late-onset pre-
eclampsia with perinatal mortality. It was 
stated that in early-onset outcomes of neo-
natal deaths were higher than late-onset 
(Simsek et al., 2016). 
14. The effect of IUGR towards pre-
eclampsia 
This study shows a significant difference in 
the incidence of IUGR between early and 
late-onset preeclampsia where early-onset 
preeclampsia patients were 51.2%, while 
late-onset was 8.3% with IUGR. This study 
is in accordance with studies in African 
women, found that fetuses with IUGR 
output were found in early-onset patients, 
and were not found in late-onset (Gathiram 
and Moodley, 2016). 
15. The effect of fetal distress/ 
hypoxia towards preeclampsia 
This study shows a significant difference in 
the incidence of fetal distress/hypoxia 
between early and late-onset preeclampsia 
where early-onset preeclampsia patients 
were 56.8% while late-onset 19.7% with 
fetal distress/hypoxia. This is in line with 
the results of research in Bandung, Indo-
nesia. It was concluded that the incidence 
of early-onset was less than late-onset, 
perinatal complications in the form of 
IUGR and fetal asphyxia were obtained in 
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early-onset preeclampsia (Aziz and 
Johanes, 2016). 
From this study, it is known that 
maternal characteristics that greatly influ-
ence the incidence of late-onset preeclamp-
sia are LDH variables where patients with 
LDH > 600 are at risk for early-onset pre-
eclampsia 4.37 (2.66 to 7.18). Other vari-
ables that affected were proteinuria and 
platelets. These results prove that the 
theory of the causes of preeclampsia is not 
only due to trophoblast invasion causes the 
failure of spiral artery remodeling, but is 
also influenced by the maternal constitu-
tion (Creasy, 2014). 
The most common complication in 
early and late-onset preeclampsia is to look 
at the OR values for each maternal and 
perinatal complication. The results showed 
that maternal mortality was the most 
common complication, followed by compli-
cations of perinatal death and complica-
tions of IUGR. This is in accordance with 
previous studies which stated that maternal 
and perinatal mortality increased 16 times 
in early-onset preeclampsia (Lisonkova and 
Joseph, 2013). 
Characteristics of patients with early 
and late-onset are more likely to lead to 
multiparity groups, this is related to 
maternal stress factors that have an impact 
on the incidence of preeclampsia. A large 
number of children (multiparity) is one of 
the causes of maternal stress. Psychological 
events such as high-stress levels, anxiety or 
depression can directly or indirectly affect 
pregnancy because it causes preeclampsia. 
Psychological stress can affect up to 18% in 
pregnant women, where there is a change 
in the functioning of the neuroendocrine 
system and the immune system. Dangerous 
conditions can directly change the hypo-
thalamic-pituitary-adrenal (HPA) axis, 
which leads to increased cortisol levels and 
related changes in cellular immunity. High 
cortisol levels are associated with hyper-
tension and endothelial dysfunction. Early-
onset preeclampsia tends to cause maternal 
complications (maternal death, eclampsia, 
pulmonary edema, HELLP syndrome) and 
perinatal complications (perinatal death, 
IUGR, and fetal distress/ fetal hypoxia). 
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